| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2004-01-0341 |
| P698 | PubMed publication ID | 15161669 |
| P50 | author | Kari Hemminki | Q63213683 |
| Xinjun Li | Q85344166 | ||
| Ruth Pfeiffer | Q90909936 | ||
| P2093 | author name string | Lynn R Goldin | |
| P433 | issue | 6 | |
| P921 | main subject | chronic lymphocytic leukemia | Q1088156 |
| P304 | page(s) | 1850-1854 | |
| P577 | publication date | 2004-05-25 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database | |
| P478 | volume | 104 |
| Q28943555 | A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia |
| Q36384877 | A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia |
| Q41880110 | A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci |
| Q47266960 | A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk |
| Q38839768 | A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes. |
| Q40077583 | ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele |
| Q92507373 | Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk |
| Q34772134 | Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders |
| Q92431571 | Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis |
| Q23917829 | Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis |
| Q91666607 | Chronic lymphocytic leukaemia: from genetics to treatment |
| Q23921281 | Chronic lymphocytic leukemia radiogenicity: a systematic review |
| Q36057875 | Chronic lymphocytic leukemia: a review of some new aspects of the biology, factors influencing prognosis and therapeutic options |
| Q24630753 | Common genetic variants in candidate genes and risk of familial lymphoid malignancies |
| Q37659388 | Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk |
| Q36141922 | Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia |
| Q36806417 | Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study |
| Q36287377 | Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia |
| Q64099080 | Elevated IgM and abnormal free light chain ratio are increased in relatives from high-risk chronic lymphocytic leukemia pedigrees |
| Q37175576 | Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia |
| Q38087743 | Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditions |
| Q34608117 | Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis. |
| Q34441264 | Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas. |
| Q35888716 | Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies |
| Q33938058 | Familial chronic lymphocytic leukemia |
| Q57319776 | Familial chronic lymphocytic leukemia |
| Q34702451 | Familial chronic lymphocytic leukemia: what does it mean to me? |
| Q38374412 | Familial leukemias |
| Q37154914 | Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia |
| Q37643423 | From pathogenesis to treatment of chronic lymphocytic leukaemia |
| Q37406801 | Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies |
| Q86775363 | Genetic susceptibility to chronic lymphocytic leukemia |
| Q33641328 | Genetic susceptibility to lymphoma |
| Q33780771 | Genetic susceptibility variants for chronic lymphocytic leukemia |
| Q37323162 | Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease |
| Q37442322 | Genetics- and immune-related factors in the pathogenesis of lymphoplasmacytic lymphoma/ Waldenström's macroglobulinemia |
| Q37637724 | Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia |
| Q29248527 | Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci |
| Q47900293 | Genome-wide association studies of cancer: current insights and future perspectives |
| Q28262604 | Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families |
| Q81544661 | High frequency of unrecognized indolent hematological disorders among HLA-matched siblings of patients with lymphoproliferative malignancies eligible for allo-SCT |
| Q37242775 | Highly increased familial risks for specific lymphoma subtypes |
| Q35038312 | Host genetics in follicular lymphoma |
| Q37383042 | Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study |
| Q42639007 | Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. |
| Q64121820 | Inheritance of Susceptibility to Malignant Blood Disorders |
| Q37319074 | Inherited predisposition to chronic lymphocytic leukemia |
| Q37073888 | Inherited susceptibility to chronic lymphocytic leukemia: evidence and prospects for the future |
| Q92534622 | Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics |
| Q64238382 | Leukemia multiclass assessment and classification from Microarray and RNA-seq technologies integration at gene expression level |
| Q35220109 | Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients. |
| Q37034615 | Male-to-female sex ratios of abnormalities detected by fluorescence in situ hybridization in a population of chronic lymphocytic leukemia patients |
| Q27694619 | Monoclonal B cell lymphocytosis: clinical and population perspectives |
| Q56461762 | Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults |
| Q37552813 | Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management |
| Q37609423 | Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding |
| Q39023986 | New emerging therapies in the management of chronic lymphocytic leukemia |
| Q37293654 | Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia |
| Q35849823 | Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries |
| Q34497732 | Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders |
| Q37247342 | Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders |
| Q37369963 | Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia |
| Q47126449 | Rare germline variants in ATM are associated with chronic lymphocytic leukemia |
| Q35642807 | Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia |
| Q36194254 | Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans |
| Q33590562 | Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis |
| Q37119385 | Survival patterns among lymphoma patients with a family history of lymphoma |
| Q42608633 | The interval between cancer diagnosis among mothers and offspring in a population-based cohort |
| Q42831544 | The molecular basis of familial chronic lymphocytic leukemia |
| Q38748645 | The molecular pathogenesis of chronic lymphocytic leukaemia |
| Q36962654 | The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia |
| Q35854831 | Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population |
| Q38150849 | Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models |
| Q37860009 | What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination? |
Search more.